학술논문

Assessing the Interchangeability of AVT02 and Humira® in Participants with Moderate‑to‑Severe Chronic Plaque Psoriasis: Pharmacokinetics, Efficacy, Safety, and Immunogenicity Results from a Multicenter, Double-Blind, Randomized, Parallel-Group Study
Document Type
Article
Source
In: BioDrugs. (BioDrugs, July 2023, 37(4):551-567)
Subject
Language
English
ISSN
1179190X
11738804